Putnam

As we mark Rare Disease Day, we reflect on the evolving landscape of rare disease therapies and the challenges ahead: ?? Global Impact: 300M+ people worldwide are affected, reinforcing the urgency for continued innovation. ?? 2025 Theme: More Than You Can Imagine—spotlighting resilience and the need for progress. ?? Advancements in Genomics: Faster genome sequencing and heightened awareness is improving diagnosis and treatment pathways. ?? Policy Shifts: Evolving regulations emphasize real-world evidence and innovative payment models. ?? Market Complexity: Access, pricing, and commercialization hurdles remain significant for manufacturers. At Putnam, we help biopharma companies navigate this complex and evolving landscape—ensuring strategic, evidence-based decisions that maximize impact. Read more here: https://lnkd.in/eDSEvKdg Mariah Hanley, Joseph Feingold #RareDiseaseDay #Innovation #Healthcare #Putnam

Attending MAPS US? Lori Klein, PharmD, Partner, Medical and Scientific Affairs Practice Lead and Erika Ray, PhD, Principal will be there and are looking forward to connecting with you. Find us at the Inizio booth 511 and during our presentations to discuss how we're transforming Medical Affairs through insights and solutions that drive innovation and deliver results. Contact us to see how we can elevate Medical Affairs together: https://lnkd.in/e8RkNfUK #MAPSUS2024 #MedicalAffairs #Putnam #Innovation #AI

Health equity is more than a goal—it’s a responsibility. Medical Affairs teams are uniquely positioned to bridge gaps, build trust, and drive meaningful change in underserved communities. In this insight by Rudiger Papsch, Partner, Erika Ray, PhD, Principal, and Sneha Dutta, Ph.D., Senior Consultant, learn how Medical Affairs can lead the charge in fostering inclusivity and equitable healthcare outcomes. Read more: https://lnkd.in/eEZSQ7Z6 #HealthEquity #MedicalAffairs #PutnamInsights #BreakingBarriers

Have you signed up for our upcoming panel discussion in NYC? We’re thrilled to be partnering with OUTbio Greater New York and our colleagues at Vynamic to co-host an engaging conversation: “From Bench to Bedside: Integrating Health Equity at Every Stage of Life Science Innovation.” Check out the insights below from our incredible speakers on what health equity means to them. Visit the OUTbio Greater New York page for more details—we can't wait to connect with you there! #HealthEquity #LifeSciences #Innovation #BenchToBedside #OUTBio #Vynamic #Putnam #NYCNetworking

We'll be attending to Medical Affairs Professional Society (MAPS) US 2024! We're looking forward to joining experts across Inizio along with other industry leaders to discuss the future of Medical Affairs. From AI-driven insights to strategic innovation, we’re ready to connect, collaborate, and shape what’s next. Contact us to see how we can elevate Medical Affairs together: https://lnkd.in/ezUkiS49 Stay tuned for more details. #MAPSUS2024 #MedicalAffairs #Putnam #Innovation #AI

Will 2025 be the tipping point for pharma commercialization? From precision engagement to AI-driven insights, the potential for transformation has never been greater. In Inizio's AI report, explore how 2025 could be the year pharma fully embraces data-driven decision-making and next-gen commercialization strategies. Download the full report here: https://lnkd.in/e6FuHBJH #AI #PharmaInnovation #FutureofHealthcare #Commercialization

Last week, we celebrated #WearRedDay through the American Heart Association. Our teams showed their support by wearing red and raising awareness for heart health. Together, we’re standing strong, showing our support, and spreading the message—because every heartbeat matters. Inizio, Inizio Advisory #HeartHealth #GoRed #WearRedDay

Exciting news! The 2025 Vault Rankings have just been announced, and we are happy to share that Putnam has been ranked highly in multiple categories. ?? Top 50 Overall: Ranked #4 ?? Best Boutique: Ranked #4 ?? Prestige: Ranked #41 ?? Health & Life Sciences: Ranked #18 These rankings are a testament to the exceptional talent, dedication, and expertise of our Putnam team. Thank you to everyone who makes our firm a leader in strategy consulting for life sciences! To learn more about these rankings, visit the Vault website here: https://lnkd.in/gkjbyKA2 #Putnam #VaultRankings #LifeSciences #Consulting #Teamwork #Excellence

In a rapidly evolving market, data-driven strategies are the key to confident commercial decisions. But how can pharma leaders cut through the noise and extract real value from their data? Our insight by Gan Hong Tan, Partner, and Bilal Babar, Analytics Director at Research Partnership explores three powerful tactics to optimize your pharmaceutical data strategy, how to blend market research and AI for smarter decision-making, and how to drive commercial success with confidence. Read more here: https://lnkd.in/ezvnPXgE #PharmaStrategy #DataDrivenDecisions #MarketResearch #AI #InizioAdvisory

Recently, the HHS and CMS announced 15 additional drugs set for Medicare Drug Price Negotiation in 2025, with Maximum Fair Prices taking effect in 2027. Back in October, our expert team accurately predicted 13 of the 15 selections—including all of the Top 10. As additional updates are provided on the next round of Medicare Drug Price Negotiations, we will continue to assess their implications for the pharmaceutical industry and Medicare beneficiaries. Read more about the 15 selected drugs here: /https://lnkd.in/eCWX4asr and our original expert predictions here: https://lnkd.in/ekcus4Zk #Medicare #Pharma #DrugPriceNegotiation #IRA